Article
STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway
8 Jul 2022
Abstract excerpt
Rheumatoid arthritis (RA), which is the most common inflammatory arthritis disease, as well as a kind of most prevalent autoimmune disease, affects 1–3% population all over the world. 1 Currently available treatments can reduce the disability rate of patients with RA to some extent, but they cannot completely block the inflammatory joint destruction and relieve the pain that comes with it. Our previous study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
